《【原美源伯根】Cencora (COR) 2017年年度报告「NYSE」.pdf》由会员分享,可在线阅读,更多相关《【原美源伯根】Cencora (COR) 2017年年度报告「NYSE」.pdf(16页珍藏版)》请在三个皮匠报告上搜索。
1、2017 Summary Annual ReportIn This Report03About AmerisourceBergen04Creating Healthier Futures05CEO Statement:To Our Stockholders102017 Overview12Management Team15Corporate InformationAbout AmerisourceBergen AmerisourceBergen is one of the largest global pharmaceutical sourcing and distribution servi
2、ces companies,helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care.With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services,AmerisourceBergen
3、delivers innovative programs and solutions across the pharmaceutical supply channel in human and animal health.With over$153 billion in annual revenue,AmerisourceBergen is headquartered in Valley Forge,PA,and employs approximately 21,000 people around the world.AmerisourceBergen is ranked#11 on the
4、Fortune 500 list.We distribute a comprehensive offering of brand name and generic pharmaceuticals-including specialty pharmaceutical products,over-the-counter healthcare products,home healthcare supplies and equipment,outsourced compounded sterile preparations,and related services to a wide variety
5、of healthcare providers located in the United States and select global markets.Our customers include chain retail and independent pharmacies,mail order pharmacies,acute care hospitals and health systems,physician practices,medical and dialysis clinics,long-term care and other alternate site pharmaci
6、es,veterinarians,and others.Additionally,we furnish healthcare providers and pharmaceutical manufacturers with an assortment of related high-value services,including reimbursement and pharmaceutical consulting services,niche premium logistics services,inventory management,pharmacy automation,and pha